Filter

Refine by collections

  • Hormones and Cancer (3)

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 3 of 3 items for :

  • "cross-sectional" x
  • Hormones and Cancer x
Clear All
Kaili Yang Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Kaili Yang in
Google Scholar
PubMed Close
,
Jiarui Li Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China

Search for other papers by Jiarui Li in
Google Scholar
PubMed Close
,
Yuejuan Cheng Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Yuejuan Cheng in
Google Scholar
PubMed Close
, and
Chunmei Bai Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Chunmei Bai in
Google Scholar
PubMed Close

information, especially defects in current research landscape ( 19 , 20 ). Besides, the scope of all NEN trials in the study may introduce additional heterogeneity. Therefore, we conducted this cross-sectional study to comprehensively illustrate the current

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0441
Volume/Issue:
Volume 12: Issue 4
Open access
Nikolaos Kyriakakis Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed Close
,
Marilena Giannoudi Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed Close
,
Satish S Kumar Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Satish S Kumar in
Google Scholar
PubMed Close
,
Khyatisha Seejore Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed Close
,
Georgios K Dimitriadis Department of Endocrinology, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close
,
Harpal Randeva Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK

Search for other papers by Harpal Randeva in
Google Scholar
PubMed Close
,
Adam Glaser Pediatric Oncology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute of Medical Research, University of Leeds, UK

Search for other papers by Adam Glaser in
Google Scholar
PubMed Close
,
Michelle Kwok-Williams Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed Close
,
Georgina Gerrard Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Georgina Gerrard in
Google Scholar
PubMed Close
,
Carmel Loughrey Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Carmel Loughrey in
Google Scholar
PubMed Close
,
Ahmed Al-Qaissi Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed Close
,
Ramzi Ajjan Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed Close
,
Julie Lynch Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Search for other papers by Julie Lynch in
Google Scholar
PubMed Close
, and
Robert D Murray Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed Close

the primary disease; however, an increase in cardiovascular mortality ( 3 ) and risk of early and late-occurring stroke ( 4 , 5 ) are also observed. There are limited cross-sectional studies evaluating conventional vascular risk factors in SCBT ( 6

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0491
Volume/Issue:
Volume 12: Issue 8
Open access
Mark J C van Treijen Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed Close
,
Catharina M Korse Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Catharina M Korse in
Google Scholar
PubMed Close
,
Wieke H Verbeek Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed Close
,
Margot E T Tesselaar Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed Close
, and
Gerlof D Valk Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Gerlof D Valk in
Google Scholar
PubMed Close

disease (PD) ( 18 ). In an independent, cross-sectional validation study, the NETest reliably predicted SD and was the strongest predictor of PD in a large group of GEPNETs ( 19 ). To date, no studies on consecutive NETest measurements in individual

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0146
Volume/Issue:
Volume 11: Issue 10
Open access